Bill Gates Announces $100 Million Investment in Alzheimer's Disease

Share

Gates has committed $50 million to the Dementia Discovery Fund in an effort to help fund research to fight Alzheimer's disease. Gates will provide this $100 million himself. Those conversations led him to focus on five areas: understanding how the disease unfolds, figuring out how to detect it earlier, funding more innovative and lesser-known drug trials, making it easier for people to enroll in clinical trials, and using data to inform better approaches.

As people continue to live longer, Gates says on his blog, the more at risk they are for developing diseases like Parkinson's or arthritis.

Gates said he's investing $50 million to the Dementia Discovery Fund- a fund that brings together non-profits, governments and private industry to identify treatments for dementia.

Microsoft co-founder and philanthropist Bill Gates talks with a colleague before the Berkshire Hathaway annual meeting in Omaha, Nebraska, U.S. May 6, 2017.

"I know how very bad it is to watch people you love struggle as the disease robs them of their mental capacity, and there is nothing you can do about it", he wrote. "It feels a lot like you're experiencing a gradual death of the person that you knew", he said in a blog post about the dementia investments. It is calling to be that everyone will need to take some major steps in context and Bill Gates is the one who comes forward and is now a mission to "Cure Alzheimer".

Alzheimer's is a form of dementia that affects more than 5 million Americans.

"We don't really have anything that stops Alzheimer's, and so the growing burden is pretty unbelievable", Gates said in an interview with CNN's chief medical correspondent, Sanjay Gupta. Stay tuned with us for more health and news feeds like this.

"In the first example of its kind in dementia, the DDF has now brought together funding from the private sector, charity and industry, and we're especially pleased to get so much interest from the United States in a British fund", said Kate Bingham, Managing Partner of SV. A more diverse drug pipeline increases our odds of discovering a breakthrough.

Gates said, however, that with focused and well-funded innovation, he's "optimistic" treatments can be found, even if they might be more than a decade away.

He was realistic by adding that he hoped that within 10 years some strong drugs were available, but there is the possibility that will not be achieved. "So, yes, I believe there is a solution".

Share